ACTEMRA® (tocilizumab) Treatment Information for Healthcare Professionals ACTEMRA is indicated for the treatment of giant cell arteritis (GCA) in adult patients ACTEMRA is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (PJIA) in patients 2 years of age and older
COVID-19 EUA Treatment Info | ACTEMRA® (tocilizumab) When ACTEMRA is used for treatment of COVID-19, ALT and AST should be monitored according to current standard clinical practice Laboratory Parameters In randomized, controlled trials, patients receiving ACTEMRA had higher rates of neutropenia, thrombocytopenia, and elevations of ALT or AST
HOW TO INJECT WITH YOUR ACTPen - actemrahcp. com What does ACTEMRA treat? ACTEMRA is a prescription medicine used to treat: • Adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease modifying antirheumatic drug (DMARD) has been used and did not work well • Adults with giant cell arteritis (GCA)
Financial Assistance Options for Giant Cell Arteritis (GCA . . . - actemra ACTEMRA is indicated for the treatment of giant cell arteritis (GCA) in adult patients ACTEMRA is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (PJIA) in patients 2 years of age and older
Giant Cell Arteritis (GCA) Treatment HCP - actemra ACTEMRA is indicated for the treatment of giant cell arteritis (GCA) in adult patients ACTEMRA is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (PJIA) in patients 2 years of age and older